Fuzzy MCDM Approach for Exploring the Opportunity of Medical & Biotech Device Industry in Taiwan
Jesse -C.H Peng
|關鍵字:||層級分析法;三角模糊數;模糊多評準決策方法;Analytical Hierarchy Process;Triangular Fuzzy Number;Fuzzy Multi-Criteria Decision Method|
The Medical Device Industry, Biotech Industry and Pharmaceuticals Industry compose the whole category of Life Science Industry. In 1997, Taiwan Government announced investment plan of totaling NT$2,000 million over 5 years into Taiwan Life Science Industry. The strengths in electronic and information industries in Taiwan constitute the competitive advantages of a medical and biotech device industry. Because there are a large variety of products in a wide-range of categories in this industry, it is important to know the strategic direction and investment priority. This thesis used a Fuzzy Multi-Criteria Decision-Making mode to consolidate opinions of experts in this field. Our analysis result concluded that technology is of the paramount importance, government policy and regulation is next, while the industry supply side and demand side structure is the third. The small and medium Businesses with innovative characteristics and precision manufacturing base have become the foundation of the Taiwan Industry. By following with the success of the electronic industry and information technology industry for the past 20 years, the Taiwan economic has been pushing forward to a newest level. Therefore, Medical & Biotech Device industry has its own monopolistic niche when considering combining the existing base with the competition chance in the future market. In consideration of the Medical & Biotech Device industry has covered a wide-ranging category, it is necessary to build up an evaluation criteria and weighting system to concentrate the limited resource and the specific advantage of Taiwan in the Medical & Biotech Device industry with the most competitiveness.The goal of this research is to establish and using the evaluation criteria on selection the best developmental direction of Medical & Biotech Device industry in Taiwan. Four phases of researches were conducted. The first phase of research was performed to screen 15 priorities as the evaluation factors chosen by the related reference. Surveying the questionnaire format through the Biotech experts, Medical Device industries and other domain specialists in Taiwan performed the second phase of research. Three major evaluation domains were then formed based on the nature of the 15 evaluation factors and five evaluation factors were arranged accordingly under each domain. A research method of Analytic Hierarchy Process was conducted to establish the evaluation criteria and weighting system. In summary, the “industrial technical capability” ranked highest amongst other domains and its weighed point is calculated as 0.114. The ranking order of weighed domains is the “industrial technical capability (0.420)”, “governmental related policies (0.311)” and “industry developmental environments (0.269)”. Regarding the top 15 evaluation factors, the ranking order of weighted top five evaluation factors is the “R&D innovation triggers (0.114)”, “technology learning capability (0.083)”, “market demanding driver (0.083)”, “biotech talents incubation policies (0.083)” and “intelligence proprietary management capability (0.082)”. The most unimportant factor is the “production capability” and weighted 0.040. Afterwards, the research methods of Triangular Fuzzy Number and Fuzzy Multi-Criteria Decision Method were conducted which were based on the opinions provided from the experts to ranking the 9 Medical & Biotech Device industries, and the evaluation sequence of the industries are Physiologic Monitoring System, Artificial Organ, Clinical Diagnostic Device, Medical Image System, Welfare Instrument, Surgical Instrument, Radial Equipment, Physiotherapy Instrument, and the last, the Liquid Transportation Device.
|Appears in Collections:||Thesis|